SonoTheratm, a biotechnology company dedicated to treating the root cause of human diseases by developing the next generation of genetic medicines, today announced it will officially launch a $125M ...

Arkstone Medical Solutions, a biotechnology company transforming Clinical Decision Support (CDS) through "Expert-in-the-Loop" machine learning (ML) and artificial intelligence (AI), today announced ...

Ven Raju, CEO of Innovation Works, is a seasoned venture investor and ecosystem builder with deep experience across ...

As the Federal Reserve seeks to meet its dual mandate to curb inflation while achieving maximum employment, CFOs must perform ...

Conditional market access schemes can accelerate access to effective new treatments. To better balance their costs and health benefits, collaborative negotiation is key in pricing.

Vamorolone is approved and marketed as AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD) in the US, European Union, UK and ChinaNew five-year data on vamorolone highlighted substantially ...

Ad hoc announcement pursuant to Art. 53 LR Exclusive licensing agreement includes USD 40 million upfront comprising USD 30 million in cash and USD 10 million equity investment at CHF 14.91 per share ...

Bayer has opened a new legal front in the long-running battles over COVID-19 vaccine technology, suing several major ...

Egyptian companies engaged in flour milling posted strong gains in 2025, led by a 315% increase at South Cairo and Giza Flour Mills. Other increases included North Cairo Flour Mills, up 217%; ...

Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Rentschler Biopharma, a global CDMO for biopharmaceuticals, and VarmX, a biotech company developing direct oral ...